Developing a UV dosing strategy for UV/chlorine process towards the trade-off between pharmaceuticals and personal care products degradation and disinfection by-products formation

Abstract

In addition to UV wavelength and pH, UV irradiation intensity and fluence also play crucial roles in the UV/chlorine treatment of drinking water. This work aimed to develop a novel UV irradiation strategy to achieve a trade-off between pharmaceuticals and personal care products (PPCPs) degradation and disinfection by-products (DBPs) formation during UV/chlorine water treatment under a specific chlorine dose. Under high UV irradiation intensity at the same UV fluence, the faster chlorine photolysis produced higher steady-state concentrations of •Cl and •OH species but abated cumulative exposures of free available chlorine (CTFAC = ∫0t[Cl2]dt). As a result, the degradation rate of PPCPs was accelerated, but the removal percentage of some PPCPs decreased. Meanwhile, the degradation of the chromophores of dissolved organic matters (DOM) declined by 23.3%–24.8% under the higher UV irradiation intensity. Reducing CTFAC values (50.7%–57.6%) by high UV irradiation intensity could mitigate the formation of haloacetic acids, trihalomethanes and absorbable organic halogens (13.9%–14.9%), which addressed the key role of active chlorine in the formation of DBPs in the UV/chlorine process. DBPs were mainly generated from the interactions of DOM with reactive chlorine. The Vibrio fischeri data further indicated that increasing UV intensity reduced acute toxicity regardless of UV wavelength or water pH. For the same UV fluence dose, the high UV irradiation intensity can effectively control the trade-off between oxidation efficiency and DBPs formation during UV/chlorine treatment.